Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors × Filgrastim × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Myelodysplastic Syndromes 15 Hodgkin Disease 11 Lymphoma, Non-Hodgkin 10 Lymphoma 8 Leukemia, Biphenotypic, Acute 8 Leukemia 8 Lymphoma, Large B-Cell, Diffuse 7 Burkitt Lymphoma 7 Breast Neoplasms 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Hematologic Neoplasms 5 Rhabdomyosarcoma 4 Neoplasms 4 Medulloblastoma 4 Lymphoma, Mantle-Cell 4 Leukemia, Myelomonocytic, Chronic 4 Anemia, Refractory, with Excess of Blasts 4 Triple Negative Breast Neoplasms 3 Neuroblastoma 3 Lymphoma, Follicular 3 Sarcoma, Ewing 2 Sarcoma 2 Recurrence 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, AIDS-Related 2

Interventions

repotrectinib 1 pralsetinib 1 ONC206 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡